Olympus Stock

Olympus Corporation engages in the manufacture and sale of medical, scientific, imaging and other products.

The Olympus Group, based on the four businesses, Medical Business, Scientific Solutions Business, Imaging Business and Others, formulates comprehensive strategies for Japan and internationally with respect to products and services handled and deploys business activities.

Medical Business: Includes gastrointestinal endoscopes, surgical endoscopes, endotherapy devices, and ultrasound endoscopes. The company provides lineup of solutions for early diagnosis, centered on gastrointestinal endoscopes, and minimally invasive therapy, primarily through endotherapy devices and surgical devices.

Scientific Solutions Business: Includes biological microscopes, industrial microscopes, industrial endoscopes, and non-destructive testing equipment.

Imaging Business: Includes digital cameras, and voice recorders.

Others: Includes biomedical materials and system development.

Strategy

The key elements of the company’s strategy are to secure strong market leader position in gastrointestinal endoscope business and improve profitability through selection and concentration; expand business in respiratory, reprocessing, endoscopic ultrasound, capsule endoscopy, and IT Fields; realize business growth in emerging markets; and expand endotherapy device business (single-use devices).

Research and Development Expenditures

For the year ended March 31, 2018, the company’s research and development expenditures recognized were ¥79,241 million.

History

Olympus Corporation was founded in 1919.